Primary Health Care — Report Cards and Feedback for PCCE
Citation(s)
Ajzen, I (1991). The theory of planned behavior. Organizational Behavior and Human Decision Processes, 50(2), 179-211.
Bies, R J., & Moag, J. S. 1986. Interactional justice; Communication criteria of fairness. In R. J. Lewicki, B. H. Sheppard, & B. H. Bazerman (Eds.), Research on negotiation in organizations, Vol. 1: 43-55. Greenwich, CT: JAI Press.
Colquitt JA On the dimensionality of organizational justice: a construct validation of a measure. J Appl Psychol. 2001 Jun;86(3):386-400. doi: 10.1037/0021-9010.86.3.386.
Konovsky, M A. (2000). Understanding procedural justice and its impact on business organizations. Journal of Management, 26(3), 489-511. https://doi.org/10.1016/S0149-2063(00)00042-8
Leventhal, H (1980). Toward a comprehensive theory of emotion. In Advances in experimental social psychology (Vol. 13, pp. 139-207). Elsevier.
Shapiro, D L., Buttner, E. H., & Barry, B. (1994). Explanations: What factors enhance their perceived adequacy? Organizational Behavior and Human Decision Processes, 58(3), 346-368.
Thibault, J , & Walker, L. (1975). Procedural justice: A social psychological analysis. Hillsdale, NJ: Lawrence Elbaum Associates.
The Effect of Personalized Report Cards and Bottom-up Framing on PCCE Performance and Attitudes
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
